LegiPlex
AI Workspace & Legislation Tracker
New Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Videos & Transcripts
Capitol Directory
US
California CA
Legislatures
2023-2024 Regular Session
Senate
Bills
SB621
CA
California Senate Bill SB621
Overview
Authors & Sponsors
Activity Timeline
Action History
Meeting Schedule
Draft Versions & Texts
Latest Draft
Compare Versions
Committee Assignments
California 2023-2024 Regular Session
California Senate Bill SB621
Introduced
2/15/23
Introduced
2/15/23
Refer
2/22/23
Refer
2/22/23
Report Pass
5/1/23
Report Pass
5/1/23
Refer
5/2/23
Report Pass
5/15/23
Report Pass
5/15/23
Engrossed
5/24/23
Engrossed
5/24/23
Refer
6/1/23
Report Pass
6/21/23
Report Pass
6/21/23
Refer
6/21/23
Refer
6/21/23
Report Pass
8/23/23
Report Pass
8/23/23
Enrolled
8/31/23
Enrolled
8/31/23
Chaptered
10/8/23
Chaptered
10/8/23
Passed
10/8/23
Passed
10/8/23
Caption
Health care coverage: biosimilar drugs.
Latest SB621 Activity
Companion Bills
No companion bills found.
Previously Filed As
CA AB347
Health care coverage: step therapy.
Similar Bills
CA AB1880
Prior authorization and step therapy.
CA AB347
Health care coverage: step therapy.
CA AB2144
Health care coverage: step therapy.
KY HB346
AN ACT relating to biosimilar medicines.
AZ SB1164
Pharmacy benefits; coverage
AZ SB1102
Pharmacy benefits; prescribing; exemption